Nurse Practitioner, Acute Care · Hutchinson, KS
NPI
1578155099
Since 2021
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
2700 E 30th Ave
Hutchinson, KS, 67502
Phone (620) 663-8484
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
193 services
Medicare patients, 2024
131
Average age 72
Drug cost, 2024
$773K
892 prescriptions
Company payments, 2025
$2,971
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jorge G Simental was code 99214 (office e&m - established), 99 times for 74 patients. In total Jorge G Simental billed 193 services in 11 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 99 | 74 | $76.32 | $7,556 |
| 99213 Office E&M - Established | Office | 62 | 56 | $51.93 | $3,219 |
By year: 2022 $7,649 for 599 services; 2023 $5,985 for 93 services; 2024 $13K for 193 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 117 | 70 | $9.51 | $1,113 |
| 80053 Clinical Chemistry | 74 | 67 | $10.30 | $762 |
| 80061 Clinical Chemistry | 66 | 65 | $12.99 | $858 |
| 85027 Blood Count | 53 | 49 | $6.16 | $327 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 41 | 41 | $18.55 | $760 |
| 85025 Blood Count | 26 | 25 | $7.67 | $200 |
| 84443 Clinical Chemistry | 20 | 20 | $16.57 | $331 |
| 82043 Clinical Chemistry | 13 | 13 | $5.67 | $73.76 |
| 82570 Clinical Chemistry | 13 | 13 | $5.09 | $66.19 |
Medicare prescription drug claims, 2024
In 2024, the drug Jorge G Simental prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 189 prescriptions and refills. In total Jorge G Simental wrote 892 Medicare prescriptions that cost $773K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 189 | 217 | 47 | $139K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 130 | 138 | 47 | $3,178 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 87 | 94 | 20 | $59K |
| Montelukast Sodium Generic | 84 | 160 | 22 | $647 |
| Prednisone Generic | 48 | 48 | 34 | $84.85 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 23 | 27 | Under 11 | $2,258 |
| Breo Ellipta Fluticasone/Vilanterol | 22 | 22 | Under 11 | $8,136 |
| Ropinirole Hcl Generic | 22 | 24 | Under 11 | $98.73 |
| Gabapentin Generic | 18 | 18 | Under 11 | $74.92 |
| Ventolin Hfa Albuterol Sulfate | 16 | 18 | Under 11 | $994 |
| Lumryz Sodium Oxybate | 15 | 15 | Under 11 | $255K |
| Clonazepam Generic | 13 | 13 | Under 11 | $47.35 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 13 | 13 | Under 11 | $5,607 |
| Wakix Pitolisant Hcl | 12 | 12 | Under 11 | $196K |
| Modafinil Generic | 12 | 12 | Under 11 | $4,409 |
Brand drugs: 468 claims; generic drugs: 424 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jorge G Simental $2,971 ($2,971 in general payments such as food, travel and fees) from 15 companies. The largest payer was Inspire Medical Systems, Inc. with $1,949.
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. INSP | 20 | $1,949 |
| Jazz Pharmaceuticals Inc. JAZZ | 4 | $276 |
| Genzyme Corporation SNY | 12 | $145 |
| Harmony Biosciences LLC HRMY | 8 | $143 |
| United Therapeutics Corporation UTHR | 3 | $73.41 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $70.07 |
| GlaxoSmithKline, LLC. GSK | 3 | $60.26 |
| Axsome Therapeutics, Inc. AXSM | 2 | $52.34 |
| Verona Pharma, Inc. VRNA | 3 | $51.45 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $47.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.